Quantifying the advantages and disadvantages of pre-placement genetic screening

Occupational and Environmental Medicine

Volumn 61, Issue 5, 2004, Pages 448-453

  Palmer, K T ^a,b   Poole, J ^b   Rawbone, R G ^c   Coggon, D ^b  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c HEALTH AND SAFETY EXECUTIVE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATOPY; COST BENEFIT ANALYSIS; EMPLOYEE; EMPLOYER; EMPLOYMENT; GENETIC SCREENING; HUMAN; INCIDENCE; MASS SCREENING; MATHEMATICAL MODEL; MATHEMATICS; MEASUREMENT; OCCUPATIONAL EXPOSURE; PREEMPLOYMENT MEDICAL EXAMINATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIZATION; WORKER;

COST-BENEFIT ANALYSIS; EMPLOYMENT; ETHICS, MEDICAL; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; OCCUPATIONAL HEALTH SERVICES; PERSONNEL SELECTION;

EID: 2442496313     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.2002.005611     Document Type: Article

References (21)

1. Shpilberg O, Dorman JS, Ferrell RE, et al. The next stage: molecular epidemiology. J Clin Epidemiol 1997;50:633-8.
2. European Society of Human Genetics Public and Professional Policy Committee. Genetic information and testing in insurance and employment: technical, social and ethical issues. EUROGAPP Project 1999-2000. Background document. Birmingham: ESHG/PPPC, 2001. Available from:http://www.eshg.org/ Insurance%20background.pdf.
3. Billings PR, Kohn MA, de Cuevas M, et al. Discrimination as a consequence of genetic screening. Am J Hum Genet 1992;50:476-82.
4. Human Genetics Commission. Public attitudes to human genetic information. London: Department of Health, 2000.
5. Human Genetics Advisory Commission Employment Working Group. The implications of genetic testing for employment. London: HGACEWG, 1999.
6. Nuffield Council on Bioethics. Genetic screening: ethical issues. London: Nuffield Council on Bioethics, 1993.
7. House of Commons Science and Technology Committee. Human genetics: the science and its consequences.
8. British Medical Association. Human genetics: choice and responsibility. Oxford: Oxford University Press, 1998:170-6.
9. Council of Europe. Convention for the Protection of Human Rights and Dignity of the Human Being with Regard to the Application of Biology and Medicine. Convention on Human Rights and Biomedicine, 1996.
10. Human Genetics Commission. Personal genetic information in employment. In: Inside information: balancing interests in the use of personal genetic data. London: HGC, 2002:137-44.
11. Rawbone RG. Future impact of genetic screening in occupational and environmental medicine. Occup Environ Med 1999;56:721-4.
12. Saltini C. A genetic marker for chronic beryllium disease. In: Mendelsohn ML, Peeters JP, Normandy MJ, eds. Biomarkers in occupational health: progress and perspectives. Washington, DC: Joseph Henry Press, 1995:293-303.
13. Gonzalez FJ. Xenobiotic-metabolizing enzymes in biomarker research. In: Mendelhson ML, Peeters JP, Normandy MJ, eds. Biomarkers in occupational health: progress and perspectives. Washington, DC: Joseph Henry Press, 1995:238-56.
14. Lappe M. Ethical issues in genetic screening for susceptibility to chronic lung disease. J Occup Med 1988;30:493-501.
15. Nicas M, Lomax G. A cost-benefit analysis of genetic screening for susceptibility to occupational toxicants. J Occup Environ Med 1999;41:535-44.
16. Soderkvist P, Ahmadi A, Akerback A, et al. Glutathione S-transferase M1 null genotype as a risk modifier for solvent-induced chronic toxic encephalopathy. Scand J Work Environ Health 1996;22:360-3.
17. Draper E. High-risk workers or high-risk work? Genetic susceptibility policies in the hazardous workplace. Int J Social Pol 1986,6:12-28.
18. Draper E. Risky business: genetic testing and exclusionary practices in the hazardous workplace. New York: Cambridge University Press, 1991.
19. Edgington K. Civil aviation. In: Cox R, Edwards F, Palmer K, eds. Fitness for work, 3rd edn. Oxford: Oxford University Press, 2000:534-8.
20. Nieuwenhuijsen MJ, Heederik D, Doekes G, et al. Exposure-response relations of α-amylase sensitisation in British bakeries and flour mills. Occup Environ Med 1999;56:197-201.
21. Bartell SM, Ponce RA, Takaro TK, et al. Risk estimation and value-of-information analysis for three proposed genetic screening programs for chronic beryllium disease prevention. Risk Analysis 2000;20:87-99.